The rise in pancreatic cancer diagnoses can be attributed to detection of smaller, early-stage endocrine cancer, and not an increase in pancreatic adenocarcinoma, according to a study published Nov.

The rising incidence of pancreatic cancer among young Americans may largely reflect previously undetected cases not a true rise in occurrence, experts say.

(“Panavance” or the “Company”), a clinical-stage pharmaceutical company advancing the development of a novel oncology therapeutic intended to improve the outcomes and quality of life for patients, ...

WEST PALM BEACH, Fla. (CBS12) — Eric Borden, a pancreatic cancer survivor, is using his personal experience to raise ...

A recent analysis of pancreatic cancer data in young adults (aged 15–39) has found that although there is an increase in ...

About Cardiff Oncology, Inc. Cardiff Oncology is a clinical ... ongoing and planned investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma (mPDAC), small cell lung cancer (SCLC) ...

In the study, 34 patients with stage 4 metastatic pancreatic cancer were randomized ... the UI team also included cancer ...

A rise in the disease in younger people was not followed by an increase in deaths, a study found, and might be a sign of ...

Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy ...

A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from ...

A team of researchers explored the potential benefits of an investigational hand therapy intervention for patients with pancreatic cancer undergoing ... With the established benefits of exercise in ...